Interestingly, it was recently shown, that only 5 of 23 (21.7%) analyzed prostate cancers from patients with a G84E mutation had an ERG fusion [38] as compared to about 50% in unselected cohorts [30]. The gene discussed is ERG; the disease is prostate cancer.